HRSA COVID-19 Claims Reimbursement for Uninsured Patients
Provider support line:
HRSA provides an electronic reimbursement portal for healthcare providers who have conducted COVID-19 testing or provided treatment for uninsured individuals on or after February 4, 2020.
Reimbursement will be made for qualifying testing and treatment services, which include:
- Specimen collection, diagnostic, and antibody testing
- Testing-related visits in the office, urgent care, emergency room, or telehealth
- Treatment including office visits, telehealth, emergency room, inpatient, outpatient/observation, skilled nursing facility, long-term acute care, acute inpatient rehab, home health, emergency ground ambulance transportation, non-emergent patient transfers via ground ambulance, and FDA approved drugs as they become available for COVID-19 treatment and administered as part of an inpatient stay
- When an FDA-approved vaccine becomes available, it will also be covered
Healthcare providers who have conducted COVID-19 testing or provided treatment for uninsured individuals with COVID-19 on or after February 4, 2020 can request claims reimbursement.
Claims will generally be reimbursed at Medicare rates, subject to available funding.
Beginning May 6, 2020, submit claims electronically through the program portal.
For complete information about funding programs, including your application status, please contact funders directly. Summaries are provided for your convenience only. RHIhub does not take part in application processes or monitor application status.